| 0.1664 -0.025 (-13.24%) | 03-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.32 |
1-year : | 0.4 |
| Resists | First : | 0.27 |
Second : | 0.34 |
| Pivot price | 0.21 |
|||
| Supports | First : | 0.15 | Second : | 0.13 |
| MAs | MA(5) : | 0.17 |
MA(20) : | 0.22 |
| MA(100) : | 0.44 |
MA(250) : | 1.35 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.9 |
D(3) : | 18  |
| RSI | RSI(14): 27.2 |
|||
| 52-week | High : | 7.03 | Low : | 0.15 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ WGRX ] has closed above bottom band by 11.0%. Bollinger Bands are 55.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 79 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.21 - 0.21 | 0.21 - 0.21 |
| Low: | 0.16 - 0.16 | 0.16 - 0.16 |
| Close: | 0.16 - 0.17 | 0.17 - 0.17 |
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Wed, 11 Mar 2026
Wellgistics Secures Preferred Pricing to Advance EBV Platform - TipRanks
Wed, 11 Mar 2026
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities - ACCESS Newswire
Wed, 11 Mar 2026
Health tech firm Wellgistics moves into $3B insurance check market - Stock Titan
Mon, 09 Mar 2026
Wellgistics Launches Forzet Medical Food for GLP-1 Patients - TipRanks
Mon, 09 Mar 2026
Wellgistics Health Reports Third Quarter 2025 Financial Results and Provides Business Update - The Gardner News
Mon, 09 Mar 2026
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM) - Bitget
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 0 (M) |
| Shares Float | 102 (M) |
| Held by Insiders | 3.913e+007 (%) |
| Held by Institutions | 56.7 (%) |
| Shares Short | 643 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.909e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -228.2 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 47.1 % |
| Return on Equity (ttm) | -83.3 % |
| Qtrly Rev. Growth | 3.408e+007 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 1.33e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|